Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Liver Diseases Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02946554
What this trial is testing

Phase II Safety Study of 2 Dose Regimens of HepaStem in Patients With ACLF

Who this might be right for
Acute-On-Chronic Liver Failure
Cellaion SA 24
Testing effectiveness (Phase 2)Study completedNCT04365933
What this trial is testing

The Oral Farnesoid X Receptor Modulator EYP001a to Assess Its Safety and Anti-viral Effect in Chronic Hepatitis B Patients in Combination With Pegylated Interferon alpha2a Alone and With Entecavir

Who this might be right for
Hepatitis B, Chronic
Enyo Pharma 20
Not applicableStudy completedNCT01447446
What this trial is testing

An Observational Study on Dual And Triple Therapies Based on Peginterferon Alfa (e.g. Pegasys) in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 4,442
Not applicableEnded earlyNCT03343756
What this trial is testing

HepaStem Long-Term Safety Registry

Who this might be right for
Urea Cycle DisorderCrigler-Najjar SyndromeAcute on Chronic Liver Failure
Cellaion SA 44
Testing effectiveness (Phase 2)Study completedNCT03020095
What this trial is testing

Efficacy and Safety of Ravidasvir + Danoprevir/r 12-week Oral Therapy in Treatment-Naive Non Cirrhotic G1 CHC Taiwan

Who this might be right for
Chronic Hepatitis C
Ascletis Pharmaceuticals Co., Ltd. 38
Not applicableStudy completedNCT00705666
What this trial is testing

Treatment of Patients With Chronic Hepatitis C With PegIntron as Monotherapy or in Combination With Ribavirin (Study P04437)(COMPLETED)

Who this might be right for
Hepatitis C, ChronicHepacivirus
Merck Sharp & Dohme LLC 789
Not applicableEnrolling By InvitationNCT07298577
What this trial is testing

Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ultrasound for Surveillance of People At-risk for Developing Hepatocellular Carcinoma in Asia in Order to Detect Early Liver Cancer

Who this might be right for
Liver CirrhosisHepatitis B, ChronicHepatitis C, Chronic+1 more
Siriraj Hospital 2,100
Not applicableUnknownNCT05965843
What this trial is testing

Intervention, Prognosis and Mechanism of Covid-19 Infection in Patients With Underlying Diseases

Who this might be right for
Chronic Liver DiseaseMalignant TumorAutoimmune Diseases+1 more
The Second Affiliated Hospital of Chongqing Medical University 480
Not applicableStudy completedNCT04032275
What this trial is testing

Correlation Between Virus and Biochemical Characteristics and Liver Histological Damage in Untreated Chronic HBV Infection

Who this might be right for
Chronic Hepatitis B
Beijing Ditan Hospital 400
Not applicableLooking for participantsNCT05170971
What this trial is testing

Fecal Microbiota Transplantation for Liver Failure

Who this might be right for
Liver Failure
Ningbo Medical Center Lihuili Hospital 60
Post-approval studies (Phase 4)Ended earlyNCT00209898
What this trial is testing

Hepatitis C Treatment of Inmates

Who this might be right for
Chronic Hepatitis C
Haukeland University Hospital 42
Testing effectiveness (Phase 2)Ended earlyNCT01433016
What this trial is testing

Detection of Hepatocellular Carcinoma (HCC) With Octanoate Breath ID Test Compared to MRI

Who this might be right for
Chronic Liver DiseaseHepatocellular Carcinoma (HCC)
Meridian Bioscience, Inc. 20
Not applicableUnknownNCT05180292
What this trial is testing

Acute Hemodynamic Response to Carvedilol in Predicting Survival in Acute on Chronic Liver Failure Patients - A Pilot Study.

Who this might be right for
Acute on Chronic Liver Failure
Institute of Liver and Biliary Sciences, India 50
Very early researchStudy completedNCT02687763
What this trial is testing

Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ Transplant

Who this might be right for
RENAL INSUFFICIENCY, CHRONICLIVER FAILURE, ACUTEHEART DISEASE
Medical University of South Carolina 5
Testing effectiveness (Phase 2)Study completedNCT02947087
What this trial is testing

Alpha-1 Antitrypsin (AAT) Enhances Islet Autograft Survival in Patients With Chronic Pancreatitis

Who this might be right for
Chronic Pancreatitis
Medical University of South Carolina 48
Testing effectiveness (Phase 2)Study completedNCT00956098
What this trial is testing

Efficacy and Safety of Oltipraz in the Patients With Liver Fibrosis and Cirrhosis

Who this might be right for
Liver FibrosisLiver Cirrhosis
HK inno.N Corporation 81
Not applicableLooking for participantsNCT06550622
What this trial is testing

Improved Sensitivity Detection of Serum HBsAg and HBsAg Reversion

Who this might be right for
Hepatitis B, Chronic
Huashan Hospital 300
Early research (Phase 1)Study completedNCT02063607
What this trial is testing

The Study of Safety, Pharmacokinetics, Pharmacodynamics of Peglamda (Peginterferon Lamda 1) on Healthy Volunteers and the Preliminary Evaluation of Peglamda and Hepasig (Ribavirin) Treatment's Effects on Chronic Hepatitis C Patients

Who this might be right for
Hepatitis C
Nanogen Pharmaceutical Biotechnology Joint Stock Company 60
Large-scale testing (Phase 3)Study completedNCT01384565
What this trial is testing

G-CSF and Erythropoetin in Survival of Patients With Decompensated Liver Disease

Who this might be right for
Chronic Liver Disease
Institute of Liver and Biliary Sciences, India 55
Testing effectiveness (Phase 2)UnknownNCT00753467
What this trial is testing

A Phase II Study to Determine the Safety and Efficacy of Interferon-gamma in Patients With Chronic Hepatitis B

Who this might be right for
Hepatitis B
Huntington Medical Research Institutes 30
Next Page